Can Myeloma Be Cured Even After Relapse? | IMS 2026

Gurbakhash Kaur, MD, of Mount Sinai discusses what the new definition of cure means for myeloma patients at IMS 2026 in Glasgow. She explains why lasting MRD and imaging negativity off treatment is the key, and how long-term CAR-T follow-up suggests some heavily treated patients may reach cure even after relapse. She also explains why ongoing bispecific therapy does not yet fit the definition, and why she expects the definition to shift as treatments improve.

If this video has helped you or a loved one, consider donating to HealthTree. Every donation helps us continue to create free and high-quality blood cancer educational content: https://give.healthtree.org/give/628617/src=htu

For an organized lesson structure, watch on our site here: https://linktr.ee/HealthTreeUniversity

Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!

Patients have the key to find cures for cancer. Learn more about HealthTree's services here: https://healthtree.org/curehub?utm_source=social+media&utm_medium=htu+youtube&utm_campaign=htu-curehub&utm_content=general

Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.

Timestamps:

0:00 Introduction: Dr. Gurbakhash Kaur, Mount Sinai

0:22 The New Definition of Cure

1:01 Why Cure Means Being Off Treatment

1:34 Can Cure Happen After Relapse? CAR-T Long-Term Data

2:13 CAR-T vs. Bispecifics and the Cure Definition

2:44 When Access Is a Barrier: Iberdomide